Publication: 4133

Publication: 4133

Ibrutinib Added to Standard Conditioning and As Consolidation Following Autologous Hematopoietic Stem Cell Transplantation (AutoHCT) for Relapsed/Refractory Activated-B-Cell Subtype Diffuse Large B-Cell Lymphoma (ABC-DLBCL): Results from the US Intergroup Double-Blind Randomized Phase III Study Alliance A051301/BMT-CTN 1201

DOI

URL

Google Scholar

Citation:: Blood vol 41 (Supplement 1) 437

Meeting Instance:: ASH 2023
Year:: 2023
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 4550

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171; U10CA180820, UG1CA233234 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG);

Corr. Author:
Authors:: Charalambos Andreadis Olivia Bobek Susan Geyer Timothy Fenske Brian Hill Patrick Stiff Eric Hsi Mitchell Horwitz Farhad Khiman Rich Little Shira Dinner Jonathan Friedberg Brad Kahl Miguel Perales Steven Devine John Leonard Nancy Bartlett

Networks:: CA824, IL017, LAPS-IL036, LAPS-MN026, LAPS-MO011, LAPS-NC010, LAPS-NY016, LAPS-OH007, LAPS-WI013, NY018, OH027, PA121

Study: Alliance-A051301
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: